Lorazepam

Over 115,000 prescription-related questions fielded on JustAnswer in 2025; weight loss drug queries surge 56% since 2023, while birth control questions dip 63% This data highlights people's desire to get immediate, trustworthy answers about drugs they’re hearing about in the news and online — whether it’s a weight-loss medication or an anxiety prescription.” — Andy Kurtzig, CEO & Founder of JustAnswer SAN FRANCISCO, CA, UNITED STATES, November 19, 2025 / EINPresswire.com / -- Consumers are increasingly turning to online medical experts to navigate complex medication choices — from trending GLP-1 medications to rising questions about anxiety and hormone treatments — according to new data from JustAnswer, the world’s largest expert platform . JustAnswer experts have fielded more than 115,000 prescription-related questions so far in 2025, but it’s the pivot in what consumers are actually asking about that reveal how dramatically patient concerns are evolving. Specifically, questions about anxiety medications, weight-loss drugs and hormone therapy have surged to dominate the conversation, while interest in categories like birth control has steadily declined. In addition, JustAnswer data showed evidence about emerging curiosity and/or discussion about medications linked to autism causes and possible treatment. “What we’re seeing is a fundamental reshaping of prescription priorities,” said JustAnswer Founder and CEO Andy Kurtzig. “People are more proactive and curious than ever — asking about new medications they’ve seen in the media, managing shortages, or trying to understand side effects and alternatives. This is one of the reasons we recently launched JustAnswer Pharmacy as an extension of our telehealthcare offering after having these conversations with our physicians.” GLP-1 Drug Questions Continue to Skyrocket Fueled by social media buzz and expanding drug availability, questions about Ozempic, Mounjaro, Wegovy, and other GLP-1 medications have risen more than 56% since 2023, hitting record highs in 2025. - Mounjaro inquiries more than doubled (+142%) from 2023 to 2025 — the fastest growth of any weight-loss drug. - Wegovy also saw a 118% increase, while Ozempic remains the most-asked-about drug overall (2,504 questions since 2023). The largest spike in this category on JustAnswer came in September 2025, coinciding with renewed public debate over shortages and widespread media coverage of celebrity use. Mental Health Medication Questions Rebound Late in 2025 Questions about Xanax, Adderall, Lorazepam, and antidepressants continue to make up one of the most active prescription categories on JustAnswer, totaling more than 13,000 questions since 2023. After a dip in 2024, question volume rebounded in late 2025, mirroring broader public conversations about stress, ADHD, and anxiety. - Xanax remains the top-searched mental health medication, accounting for 40% of all mental health–related questions (5,506 total). - Adderall inquiries declined (–31% since 2023), but 2025 saw a rebound during back-to-school and work transitions. - Mentions of Lorazepam rose notably in early 2025, coinciding with its appearance in The White Lotus TV series. Hormone Therapy Sees a Late-Year Rebound Although total hormone-related questions on JustAnswer declined slightly over the past three years (–21% from 2023 to 2025), the trend turned upward again in 2025, especially for hormone replacement therapy (HRT) – likely influenced by broad media coverage and increased advertising in the menopause telehealth space. - HRT inquiries increased 21% year-over-year in 2025, peaking in September. - Broader “Hormone Therapy” questions rose 34% since 2023, suggesting growing awareness of treatment options beyond testosterone, which still accounts for 72% of all hormone-related inquiries. Emerging Curiosity Around Medications Linked to Possible Autism Causes and Treatment While not a prescription drug, one OTC medication did see a meaningful increase within the data. Tylenol questions rose significantly in late 2025, peaking in September, aligning with the public debate sparked by comments from Donald Trump and Robert F. Kennedy Jr. claiming a link between acetaminophen and autism. On the other end of the autism discussion, another drug saw a singular spike this fall: Leucovorin, a medication sometimes discussed in relation to autism, received 1,200% more questions YOY in 2025, peaking in October. This marks the sharpest growth in any prescription drug category on the platform and likely reflects new awareness generated by the MAHA movement, online communities and media discussions around emerging off-label uses for treatment of autism in children. Category in Decline: Birth Control On the other hand, questions about birth control, Mifepristone, and Misoprostol have declined on JustAnswer by 63% since 2023, signaling reduced public engagement with these medications. “Overall, this data highlights the desire for people to get immediate, trustworthy answers about new drugs they’re hearing about in the news and online — whether it’s a weight-loss medication or an anxiety prescription — and platforms like ours give them that access in real time,” said Kurtzig. “And now with JustAnswer Pharmacy, they also have a convenient, affordable way to acquire these and many prescription medications they need under medical supervision.” About JustAnswer JustAnswer is the world’s largest expert platform that connects people with live doctors, lawyers, vets, mechanics, and other verified professionals for real-time, online help. Featuring more than 20,000 experts across 150 categories, JustAnswer has helped millions of customers across 196 countries since 2003. Aimee Grove Smitten Communications aimee@smittencomm.com Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

菊花，作为中国传统文化和药用植物的重要代表，近年来迎来了跨越式的发展。 从新品种的突破到智能化种植技术的应用，再到药用价值的新发现，行业正处于快速变革之中。 这些变化不仅推动菊花产业的升级，也为相关产业带来新的机遇与挑战。 首先，2023年中国农业科学院成功培育的“彩虹菊”堪称行业一大里程碑。 这个由基因编辑技术打造的新品种，单株呈现七色渐变，宛如天空中的彩虹映衬在花丛中，令人惊叹。 彩虹菊不仅具有丰富的色彩层次，还兼具抗病性和花期延长的优势，前者抗白粉病提升60%，后者单朵花期可达45天。 这意味着，未来享誉盛名的菊花，不仅在观赏价值上突飞猛进，更在抗病抗逆能力上取得了实质性突破。 此次亮相北京世园会，亦代表着我国在花卉育种技术上的自主创新能力逐步走向世界前沿。 而在种植技术方面，2023年浙江杭白菊的“5G+物联网”智慧农业试点也令人耳目一新。 利用土壤传感器实时监控pH、湿度等12项参数，结合先进AI算法，实现精准灌溉和施肥。 这一创新措施带来显著成效：绿原酸含量提升23%，亩产增加18%，同时节水率达35%。 通过技术赋能，菊花的药用价值被最大化释放，同时也降低了生产成本，推动产业向高质量、可持续发展转型。 这一模式未来有望在全国乃至全球范围内推广，助力传统花卉迈入智慧农业的新纪元。 药用方面的最新科研成果也令人振奋。2024年《自然-植物》期刊发表的研究揭示，滁菊中的“菊甙D”成分，表现出显著的抗焦虑作用。 这一发现的价值在于其效果相当于药物劳拉西泮的72%，但没有成瘾风险。 安徽亳州建立的2000亩GAP药用菊标准化基地，也开始将这种新药理作用转化为实际产品，进入临床试验阶段。 这意味着，未来菊花不再仅仅是观赏植物或传统中药，更可能成为新药研发的重要原料，推动中医药现代化进程。 在行业层面，最新数据显示，全球菊花品种已达3876个，超过以往的3000多个，彰显产业繁荣。 从市场规模来看，药用菊市场达到54.3亿元，且食用菊的年产已上升至12万吨，其中出口占比高达30%。 这些数据背后，是中国作为花卉大国的产业韧性和创新能力，无疑为产业提供了坚实的市场基础和发展动力。 当然，快速发展也伴随着风险。 基因编辑品种严格遵守《农业转基因生物安全管理条例》，防止潜在的生态安全隐患；药用菊的成分提取和应用需要获得药品生产许可证，以保障品质安全；而智能化设备的投入，也应结合成本效益进行科学分析，确保可持续发展。 这些风险提示提醒行业在追求创新的同时，也要强化标准和监管，确保健康有序发展。 综上所述，2023-2024年菊花行业呈现出多维度的创新与突破。 从新品种的诞生，到智慧农业的推广，再到药用新成分的发现，行业正站在一个高质量发展的风口浪尖。 这场变革，不仅提升了菊花产业的整体竞争力，也为全球花卉行业提供了宝贵的中国方案。 未来，随着科技与传统的深度融合，菊花将在美丽、健康与产业价值上，呈现更加绚丽的图景。 这不仅是一个花卉的春天，更是一场智慧与创新的盛宴。